XIX International AIDS Conference opening ceremony. Speeches by the Elizabeth Taylor award winners of 2012, political and religious leaders, leaders of international agencies such as UNAIDS, IAS, The Global Fund, The World Bank and UN, and many other delegates.

XIX International AIDS Conference in Washington D.C. Memory session of the AIDS activist Robert Carr, discussing discrimination of women, MSM, sex workers and drug users as well as people living with HIV/AIDS, and tributing Robert's work and friendship.

Opening press conference on the ending of AIDS at the XIX International AIDS Conference in Washington D.C. with congress woman Barbara Lee, the Director of IAS Elly Katabira, among others. A demonstration for the rights of sex workers and drug users takes place.

XVII International AIDS Conference in Mexico City. Interview with Michel Sidibé who became the Director of UNAIDS in 2009. Here he talks about the importance of the international AIDS conferences for bringing in a human rights perspective on the global HIV/AIDS movement.

XVII International AIDS Conference in Mexico City. Interview with Dr Mervyn Silverman from San Francisco, who has been active in the AIDS movement since the early 80's. Here he reflects on the leadership of UNAIDS Director Peter Piot.

This is a short film about the global HIV and AIDS response lead by the young generation. Youths and representatives of community networks and health care centers in Cambodia, United States, Mexico, Botswana, Russia and India talk about HIV awareness and prevention.

XVI International AIDS Conference in Toronto. Panel session on health policy with Swedish AIDS Ambassador Lennart Hjelmåker, UNAIDS Executive Director Peter Piot, Indian Minister of Health Anbunmani Romdass, Sipho Mthathi from TAC and Jeffrey Sturchio from Merck.

Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.